Dr. Donna Luisi earned a Ph.D. in Chemistry from the State University of New York at Stony Brook, with thesis work on protein folding, followed by postdoctoral training at Yale University. Donna joined Pfizer (then Wyeth Biopharma) in 2001 where she has focused on formulation development of biologics and dosage form design with an emphasis on biophysical characterization. During her time at Pfizer she has served as a group lead, lead the Biophysical Center of Emphasis and contributed to a number of licensures specifically in the area of oncology. Along with current project leadership responsibilities Donna now serves as a member of the Dosage and Administration working group. Her focus has been parenteral dosage and administration instructions, in-use stability and compatibility issues, as well as interface with the clinic while gaining knowledge of how products are handled by pharmacy. Donna is currently a Senior Principal Scientist in the Pharmaceutical Research and Development group at Pfizer.